Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.
Exendin 4 (Ex4) is a glucagon-like peptide-1 receptor (GLP- 1R) agonist which is available as a short-acting injectable treatment for type 2 diabetes. Our aim was to characterize the long-term effects of elevated steady-state levels of Ex4 provided by in vivo gene therapy. We constructed a helper-dependent adenoviral (HDAd) vector for long-term expression of Ex4 in vivo. A high-fat diet (HFD)-induced obesity (DIO) mouse model was chosen to approximate the metabolic derangements seen in obese patients. Mice were treated with a single injection of HDAd-Ex4 and were monitored for 15 weeks. Both hepatic Ex4 RNA and plasma Ex4 were detectable at the end of the study. HDAd-Ex4 treatment improved glucose homeostasis without increasing insulin levels. However, there was evidence of enhanced insulin action and decreased gluconeogenic enzyme expression. HDAd-Ex4 caused decreased weight gain without detectable changes in food intake, in part, due to increases in energy expenditure (EE). HDAd-Ex4 DIO mice also had reduced hepatic fat and an improved adipokine profile. In the liver, there was decreased expression of genes that were involved in de novo fatty acid synthesis. These observations are important in considering the development of longer acting GLP-1R agonists for the treatment of type 2 diabetes.
Samson
Susan L
SL
Division of Diabetes and Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.
Gonzalez
Erica V
EV
Yechoor
Vijay
V
Bajaj
Mandeep
M
Oka
Kazuhiro
K
Chan
Lawrence
L
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D002478:Cells, Cultured; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000628:therapy*; D004041:Dietary Fats; D004435:Eating; D000077270:Exenatide; D015316:Genetic Therapy; D005822:Genetic Vectors; D000067757:Glucagon-Like Peptide-1 Receptor; D005947:Glucose / Q000378:metabolism; D006378:Helper Viruses / Q000235:genetics*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D009765:Obesity / Q000209:etiology / Q000628:therapy*; D010455:Peptides / Q000235:genetics*; D018027:Receptors, Glucagon / Q000819:agonists; D014688:Venoms / Q000096:biosynthesis / Q000235:genetics*
D004041:Dietary Fats; C000593834:Glp1r protein, mouse; D000067757:Glucagon-Like Peptide-1 Receptor; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D000077270:Exenatide; D005947:Glucose
Diabetes. 2004 May;53(5):1326-35
15111503
Horm Metab Res. 2004 Nov-Dec;36(11-12):830-6
15655715
Diabetes. 1994 Apr;43(4):535-9
8138058
Diabetes. 2007 Jun;56(6):1671-9
17369525
Mol Ther. 2003 Apr;7(4):478-83
12727110
Gene Ther. 2007 Jan;14(1):38-48
16929351
J Biol Chem. 2006 Jul 14;281(28):18933-41
16687413
Endocrinology. 2005 Apr;146(4):2069-76
15618356
J Biol Chem. 2000 Nov 3;275(44):34471-7
10952981
Trends Endocrinol Metab. 2007 Aug;18(6):240-5
17629492
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
J Am Soc Nephrol. 2007 Apr;18(4):1227-38
17360951
Trends Endocrinol Metab. 2008 Mar;19(2):65-73
18291668
Diabetes. 2000 Mar;49(3):424-30
10868964
Gastroenterology. 2004 Aug;127(2):546-58
15300587
Biochem Pharmacol. 2002 Mar 1;63(5):993-6
11911852
Gene Ther. 2007 Feb;14(3):191-202
16957769
J Appl Physiol (1985). 2004 Sep;97(3):991-7
15133003
Am J Clin Nutr. 2006 Sep;84(3):556-60
16960169
Curr Protoc Mol Biol. 2005 Feb;Chapter 16:Unit 16.24
18265354
Gene Ther. 2007 Jan;14(2):162-72
16943856
Mol Cell Endocrinol. 2003 Jun 30;204(1-2):43-50
12850280
Diabetologia. 2005 Jul;48(7):1380-5
15915337
Biochem Biophys Res Commun. 2005 Oct 14;336(1):215-22
16125673
Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1427-35
12776726
Hepatology. 2004 Oct;40(4):783-6
15382158
Peptides. 2006 Jan;27(1):157-64
16154233
Diabetes. 1999 May;48(5):1026-34
10331407
Pharmacol Rev. 2003 Mar;55(1):167-94
12615957
Gastroenterology. 2008 Feb;134(2):556-67
18242221
Physiol Rev. 2007 Oct;87(4):1409-39
17928588
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):943-8
17213311
Diabetes. 2008 Feb;57(2):288-97
17977951
FEBS Lett. 1997 Sep 29;415(2):134-8
9350983
Gastroenterology. 2008 Apr;134(4):1137-47
18313669
Diabetes. 2006 Jun;55(6):1562-70
16731818
J Biol Chem. 2003 Dec 19;278(51):51664-72
14534295
Int J Obes Relat Metab Disord. 2000 Mar;24(3):288-98
10757621
Diabetes Care. 2007 Jun;30(6):1487-93
17353504
Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E671-8
12626323
Diabetes. 2007 Jan;56(1):8-15
17192459
Diabetes Obes Metab. 2008 Sep;10(10):921-30
18093209
Hum Gene Ther. 1999 Nov 1;10(16):2667-72
10566894
Cell Metab. 2007 Dec;6(6):484-96
18054317
Diabetes. 2006 Dec;55(12):3387-93
17130484
Hepatology. 2006 Jan;43(1):173-81
16374859
J Biol Chem. 1992 Apr 15;267(11):7402-5
1313797
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):937-42
17213325
World J Gastroenterol. 2007 Jul 14;13(26):3540-53
17659704
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
15181022